S, T., T, U., A, K., F, H., T, T., T, I., . . . T, O. (2025). ABCB1 and ABCC10 polymorphisms predict sensitivity to first- and third-generation EGFR-TKIs in EGFR-mutant NSCLC. Investigational new drugs, 43(6), 1222. https://doi.org/10.1007/s10637-025-01594-9
Chicago Style (17th ed.) CitationS, Toda-Shiraga, et al. "ABCB1 and ABCC10 Polymorphisms Predict Sensitivity to First- and Third-generation EGFR-TKIs in EGFR-mutant NSCLC." Investigational New Drugs 43, no. 6 (2025): 1222. https://doi.org/10.1007/s10637-025-01594-9.
MLA (9th ed.) CitationS, Toda-Shiraga, et al. "ABCB1 and ABCC10 Polymorphisms Predict Sensitivity to First- and Third-generation EGFR-TKIs in EGFR-mutant NSCLC." Investigational New Drugs, vol. 43, no. 6, 2025, p. 1222, https://doi.org/10.1007/s10637-025-01594-9.